Meningitis: all 268 studies

Page 3 of 3. Open to participants first (28), then studies with results posted, then the rest; newest registration first within each.

• Immunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate VaccineCompletedNCT02003495Phase 3
• Immunogenicity and Safety of Group A, C, Y and W135 Meningococcal Polysaccharide VaccineCompletedNCT02003313Phase 3
• Understanding Pneumococcal Carriage and DiseaseCompletedNCT01996007
• Feasibility Study of Auditory Brainstem Implant in Young ChildrenWithdrawnNCT01850225Phase 1
• Pharmacological Study of High Doses of Ceftriaxone in MeningitidisCompletedNCT01745679Phase 4
• Interest of the Detection of Hyper-virulent Clone ST17 of Group B Strep (GBS) for the Prevention of Neonatal GBS MeningitisCompletedNCT01719510Not applicable
• Nervous System Infections Among Patients With Febrile SeizureCompletedNCT01694524
• Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 003CompletedNCT01661751Phase 3
• Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 002CompletedNCT01661738Phase 2
• Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 001CompletedNCT01661725Phase 1
• Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean ChildrenStatus unknownNCT01619462Phase 3
• Understanding the Immune Response to Two Different Meningitis VaccinesCompletedNCT01593514Phase 4
• Phase 3 Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate VaccineCompletedNCT01580033Phase 3
• Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days of Age With Probable and Confirmed MeningitisCompletedNCT01554124Phase 1/2
• Daptomycin in Pediatric Patients With Bacterial MeningitisTerminatedNCT01522105Phase 1
• Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for MeningitisCompletedNCT01482052Phase 1
• Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareCompletedNCT01431326
• Immunogenicity and Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Infants and ChildrenCompletedNCT01428908Phase 3
• Validation of Vital Signs and Symptoms for the Diagnosis of Serious Infections in Children in the Paediatric A&E.CompletedNCT01396798
• A Study of Doripenem in CerebrospinalFluid After Doripenem Administration in Pediatric Patients Less Than 1 Year of AgeTerminatedNCT01366651Phase 1
• Expanded Access to MGAWN1 in Subjects With Suspected West Nile Neuroinvasive Disease; Suspected West Nile Virus Infection; or Substantial Accidental ExposureNo longer availableNCT01206504
• Intravenous Immune Globulin (IVIG) to Prevent Neonatal InfectionCompletedNCT01203345Phase 2/3
• Comparison of Two Meningococcal ACWY Conjugate VaccinesCompletedNCT01192997Phase 2/3
• Characterization and Differential Diagnosis of Postneurosurgical MeningitisCompletedNCT01122537
• Study on the Impact of Vaccination With a Conjugate Vaccine on Meningococcal CarriageCompletedNCT01119482Phase 4
• Study of Meningococcal B Vaccine and ACWY Conjugate Vaccine in Healthy AdultsCompletedNCT00962624Phase 2
• Understanding the Immune Response to Meningitis VaccinesCompletedNCT00901940Phase 3
• Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic DermatitisCompletedNCT00801957Phase 2
• IHPOTOTAM : Induced HyPOthermia TO Treat Adult MeningitisTerminatedNCT00774631Phase 4
• Ceftazidime Pharmacokinetic in Cerebrospinal Fluid Between Continuous and Intermittent AdministrationStatus unknownNCT00752882Phase 2
• Study Evaluating Streptococcus Pneumoniae Serotype Carriage Rate for Nasopharyngeal Carriage in Filipino ChildrenCompletedNCT00724828
• Procalcitonin Level and Kinetics in Children With Bacterial InfectionsCompletedNCT00714402
• Effect of Vitamin A in the Treatment of Neonatal Sepsis and Necrotizing EnterocolitisCompletedNCT00707785Phase 3
• Phase 1 Intrathecal Topotecan for Neoplastic MeningitisCompletedNCT00674674Phase 1
• Safety and Immunogenicity of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in ToddlersCompletedNCT00631995Phase 1
• Study Evaluating the Safety and Ability to Produce Immune Response of Prevenar and Meningitec Given at the Same TimeCompletedNCT00581035Phase 4
• Impact of Daily Zinc Supplementation to Infants Born With Low Birth Weight on Death and Severe DiseaseCompletedNCT00495690Phase 3
• Colombia Epidemiologic Surveillance StudyTerminatedNCT00428051
• Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus InfectionsCompletedNCT00427076Phase 3
• Urinary Excretion of Enteroviruses From Children With a Presumed Enteroviral InfectionCompletedNCT00426699
• Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV InfectionCompletedNCT00371878Phase 4
• Amikacin Penetration Into the Cerebrospinal FluidWithdrawnNCT00362245Phase 4
• Does Static Ultrasound-Preview Reduce the Incidence of Difficult Lumbar Puncture?TerminatedNCT00317382Not applicable
• Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide VaccineCompletedNCT00271479Phase 4
• Neonatal Immunization With Pneumococcal Conjugate Vaccine in Papua New GuineaCompletedNCT00219401Phase 2
• Determination of Gentamicin Dosing in Neonatal PatientsCompletedNCT00198601Phase 4
• Effect of Meningococcal Conjugate Vaccine on Meningococcal CarriageCompletedNCT00119080Phase 4
• Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT GemcitabineTerminatedNCT00074607Phase 1
• DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid TumorCompletedNCT00029523Phase 4
• Study and Surgical Treatment of SyringomyeliaCompletedNCT00011245
• The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal MeningitisCompletedNCT00002316Phase 1
• A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin BCompletedNCT00002306Not applicable
• A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal MeningitisCompletedNCT00002305Not applicable
• A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDSCompletedNCT00002294Not applicable
• A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis.CompletedNCT00002113Not applicable
• An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal MeningitisCompletedNCT00002077Not applicable
• Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal MeningitisCompletedNCT00002076Not applicable
• Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal MeningitisCompletedNCT00002075Not applicable
• Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency SyndromeCompletedNCT00002074Not applicable
• A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal MeningitisCompletedNCT00002068Not applicable
• Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal MeningitisCompletedNCT00002040Not applicable
• Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency SyndromeCompletedNCT00002019Not applicable
• Open, Non-Comparative Study of Fluconazole in Patients With Coccidioidal MeningitisCompletedNCT00002010Not applicable
• Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDSCompletedNCT00001017Phase 3
• Dexamethasone in Cryptococcal MeningitisCompletedNCT00000776Phase 2
• Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal MeningitisCompletedNCT00000708Not applicable
• SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance TherapyCompletedNCT00000677Phase 1
• A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal MeningitisCompletedNCT00000639Not applicable

← Meningitis overview